We are live on ! Find out more
BBNX

Beta Bionics
BBNX

116 hedge funds and large institutions have $659M invested in Beta Bionics in 2025 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 37 increasing their positions, 28 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

115% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 13

32% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 28

30% more capital invested

Capital invested by funds: $508M → $659M (+$151M)

14% more funds holding

Funds holding: 102 → 116 (+14)

7.25% more ownership

Funds ownership: 96.2% → 103.45% (+7.2%)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

Holders
116
Holders Change
+14
Holders Change %
+13.73%
% of All Funds
1.53%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
28
Increased
37
Reduced
28
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$21.9M
2
DSCM
Divisadero Street Capital Management
Florida
+$13.4M
3
FCM
Farallon Capital Management
California
+$12.3M
4
VPC
Vestal Point Capital
New York
+$7.79M
5
Millennium Management
Millennium Management
New York
+$7.68M

Top Sellers

Rank Fund Capital Flow
1
AllianceBernstein
AllianceBernstein
Tennessee
-$12.8M
2
BlackRock
BlackRock
New York
-$8.05M
3
PVI
Pura Vida Investments
New York
-$6.04M
4
Citadel Advisors
Citadel Advisors
Florida
-$5.75M
5
Holocene Advisors
Holocene Advisors
New York
-$4.77M
Name Holding Trade Value Shares
Change 		Change in
Stake
EAM
1
Eventide Asset Management
Massachusetts
$71.8M +$61.3K +4,332 +0.1%
FCM
2
Farallon Capital Management
California
$61.2M +$12.3M +871,700 +26%
Wellington Management Group
3
Wellington Management Group
Massachusetts
$56.7M – – –
SCM
4
Soleus Capital Management
Connecticut
$55.6M +$6.01M +424,817 +13%
SCV
5
Sands Capital Ventures
Virginia
$52M +$6.6M +466,331 +15%
RI
6
RTW Investments
New York
$48M -$9.61K -679 -0%
Morgan Stanley
7
Morgan Stanley
New York
$42.9M +$21.9M +1,547,712 +110%
OFM
8
Omega Fund Management
Massachusetts
$28.9M – – –
PA
9
Perceptive Advisors
New York
$23.2M – – –
DM
10
Deerfield Management
New York
$17M +$2.16M +152,415 +15%
DCM
11
Driehaus Capital Management
Illinois
$16.9M +$3.93M +277,460 +31%
DSCM
12
Divisadero Street Capital Management
Florida
$13.8M +$13.4M +948,965 New
ACH
13
ArrowMark Colorado Holdings
Colorado
$13.5M -$95.8K -6,765 -0.7%
BlackRock
14
BlackRock
New York
$12.5M -$8.05M -568,791 -40%
Holocene Advisors
15
Holocene Advisors
New York
$11.2M -$4.77M -336,961 -30%
Vanguard Group
16
Vanguard Group
Pennsylvania
$10.3M -$32.4K -2,287 -0.3%
Janus Henderson Group
17
Janus Henderson Group
United Kingdom
$9.69M – – –
Marshall Wace
18
Marshall Wace
United Kingdom
$8.95M -$831K -58,693 -9%
VPC
19
Vestal Point Capital
New York
$8.01M +$7.79M +550,000 New
Millennium Management
20
Millennium Management
New York
$7.89M +$7.68M +542,198 New
Citadel Advisors
21
Citadel Advisors
Florida
$7.86M -$5.75M -406,387 -43%
RCM
22
RA Capital Management
Massachusetts
$7.28M – – –
PVI
23
Pura Vida Investments
New York
$6.25M -$6.04M -426,620 -99%
Lord, Abbett & Co
24
Lord, Abbett & Co
New Jersey
$6.11M +$2.71M +191,238 +84%
T. Rowe Price Associates
25
T. Rowe Price Associates
Maryland
$4.63M -$4.51M -318,261 -50%
1
2 3 4 5

BBNX Hedge Fund Activity: Q2 2025 in Review

116 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Beta Bionics (BBNX) for Q2 2025, worth a combined $659M — up 30% from $508M a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new BBNX positions and 13 closed out — a net gain of 15 holders — while 37 added to existing stakes and 28 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $21.9M. The largest seller was AllianceBernstein, cutting an estimated $12.8M.

  • 116 institutional investors held Beta Bionics (BBNX) as of Q2 2025, up from 102 in Q1 2025.
  • Funds reported $659M of Beta Bionics stock for Q2 2025, up 30% quarter-over-quarter.
  • 28 funds opened new Beta Bionics positions in Q2 2025 and 13 closed out, a net change of +15 holders.
  • The largest Beta Bionics buyer in Q2 2025 was Morgan Stanley, an estimated $21.9M added.
  • The largest Beta Bionics seller in Q2 2025 was AllianceBernstein, an estimated $12.8M sold.

Based on aggregated 13F filings for Q2 2025.